NextGen’s mission is to create a new generation of targeted human therapeutics which are safe and effective against a broad range of cancers and infectious diseases.

NextGen Bioscience Inc is a drug development biotechnology company focused on the identification, evaluation and acquisition of drug candidates for treatment and prevention of oncological and infectious diseases in human beings. All product candidates target indications with significant unmet need and substantial market potential. Subsequent value-addition at low cost brings benefits to both patients and stakeholders. These programmes will then be transferred to larger organizations, either other biotech companies and/or Big Pharma, who have the infrastructure to bring the products to market.

BACK TO TOP